調査レポート | • レポートコード：GIR-2104Z08730 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、マラリアワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マラリアワクチンの種類別市場規模（前赤血球ワクチン、赤血球ワクチン、多抗原ワクチン）、用途別市場規模（病院、診療所、コミュニティセンター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・マラリアワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline Plc、Sanaria Inc、Nobelpharma Co、Sumaya Biotech、GenVec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：前赤血球ワクチン、赤血球ワクチン、多抗原ワクチン ・用途別分析2016年-2026年：病院、診療所、コミュニティセンター ・マラリアワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・マラリアワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・マラリアワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・マラリアワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・マラリアワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Malaria Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Malaria Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Malaria Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Malaria Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Market segment by Application can be divided into
Hospitals
Clinics
Community Centers
The key market players for global Malaria Vaccines market are listed below:
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Malaria Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Malaria Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Malaria Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Global Malaria Vaccines Market Size & Forecast
1.4.1 Global Malaria Vaccines Sales in Value (2016-2026))
1.4.2 Global Malaria Vaccines Sales in Volume (2016-2026)
1.4.3 Global Malaria Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Malaria Vaccines Production Capacity Analysis
1.5.1 Global Malaria Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Malaria Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Malaria Vaccines Market Drivers
1.6.2 Malaria Vaccines Market Restraints
1.6.3 Malaria Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline Plc
2.1.1 GlaxoSmithKline Plc Details
2.1.2 GlaxoSmithKline Plc Major Business
2.1.3 GlaxoSmithKline Plc Malaria Vaccines Product and Services
2.1.4 GlaxoSmithKline Plc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanaria Inc
2.2.1 Sanaria Inc Details
2.2.2 Sanaria Inc Major Business
2.2.3 Sanaria Inc Malaria Vaccines Product and Services
2.2.4 Sanaria Inc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Nobelpharma Co
2.3.1 Nobelpharma Co Details
2.3.2 Nobelpharma Co Major Business
2.3.3 Nobelpharma Co Malaria Vaccines Product and Services
2.3.4 Nobelpharma Co Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sumaya Biotech
2.4.1 Sumaya Biotech Details
2.4.2 Sumaya Biotech Major Business
2.4.3 Sumaya Biotech Malaria Vaccines Product and Services
2.4.4 Sumaya Biotech Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GenVec
2.5.1 GenVec Details
2.5.2 GenVec Major Business
2.5.3 GenVec Malaria Vaccines Product and Services
2.5.4 GenVec Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Malaria Vaccines Sales by Manufacturer
3.1 Global Malaria Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Malaria Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Malaria Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Malaria Vaccines Manufacturer Market Share
3.4.2 Top 6 Malaria Vaccines Manufacturer Market Share
3.5 Global Malaria Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Malaria Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Malaria Vaccines Market Size by Region
4.1.1 Global Malaria Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Malaria Vaccines Revenue by Region (2016-2026)
4.2 North America Malaria Vaccines Revenue (2016-2026)
4.3 Europe Malaria Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Malaria Vaccines Revenue (2016-2026)
4.5 South America Malaria Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Malaria Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Malaria Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Malaria Vaccines Revenue by Type (2016-2026)
5.3 Global Malaria Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Malaria Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Malaria Vaccines Revenue by Application (2016-2026)
6.3 Global Malaria Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Malaria Vaccines Sales by Type (2016-2026)
7.2 North America Malaria Vaccines Sales by Application (2016-2026)
7.3 North America Malaria Vaccines Market Size by Country
7.3.1 North America Malaria Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Malaria Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Malaria Vaccines Sales by Type (2016-2026)
8.2 Europe Malaria Vaccines Sales by Application (2016-2026)
8.3 Europe Malaria Vaccines Market Size by Country
8.3.1 Europe Malaria Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Malaria Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Malaria Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Malaria Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Malaria Vaccines Market Size by Region
9.3.1 Asia-Pacific Malaria Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Malaria Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Malaria Vaccines Sales by Type (2016-2026)
10.2 South America Malaria Vaccines Sales by Application (2016-2026)
10.3 South America Malaria Vaccines Market Size by Country
10.3.1 South America Malaria Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Malaria Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Malaria Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Malaria Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Malaria Vaccines Market Size by Country
11.3.1 Middle East & Africa Malaria Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Malaria Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Malaria Vaccines Typical Distributors
12.3 Malaria Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Malaria Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Malaria Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Plc Major Business
Table 5. GlaxoSmithKline Plc Malaria Vaccines Product and Services
Table 6. GlaxoSmithKline Plc Malaria Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanaria Inc Basic Information, Manufacturing Base and Competitors
Table 8. Sanaria Inc Major Business
Table 9. Sanaria Inc Malaria Vaccines Product and Services
Table 10. Sanaria Inc Malaria Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Nobelpharma Co Basic Information, Manufacturing Base and Competitors
Table 12. Nobelpharma Co Major Business
Table 13. Nobelpharma Co Malaria Vaccines Product and Services
Table 14. Nobelpharma Co Malaria Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sumaya Biotech Basic Information, Manufacturing Base and Competitors
Table 16. Sumaya Biotech Major Business
Table 17. Sumaya Biotech Malaria Vaccines Product and Services
Table 18. Sumaya Biotech Malaria Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GenVec Basic Information, Manufacturing Base and Competitors
Table 20. GenVec Major Business
Table 21. GenVec Malaria Vaccines Product and Services
Table 22. GenVec Malaria Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Malaria Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Malaria Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Malaria Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Malaria Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Malaria Vaccines Production Site of Key Manufacturer
Table 28. Global Malaria Vaccines Sales by Region (2016-2021e) & (K Units)
Table 29. Global Malaria Vaccines Sales by Region (2021-2026) & (K Units)
Table 30. Global Malaria Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Malaria Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Malaria Vaccines Sales by Type (2016-2021e) & (K Units)
Table 33. Global Malaria Vaccines Sales by Type (2021-2026) & (K Units)
Table 34. Global Malaria Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Malaria Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Malaria Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Malaria Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Malaria Vaccines Sales by Application (2016-2021e) & (K Units)
Table 39. Global Malaria Vaccines Sales by Application (2021-2026) & (K Units)
Table 40. Global Malaria Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Malaria Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Malaria Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Malaria Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Malaria Vaccines Sales by Country (2016-2021e) & (K Units)
Table 45. North America Malaria Vaccines Sales by Country (2021-2026) & (K Units)
Table 46. North America Malaria Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Malaria Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Malaria Vaccines Sales by Type (2016-2021e) & (K Units)
Table 49. North America Malaria Vaccines Sales by Type (2021-2026) & (K Units)
Table 50. North America Malaria Vaccines Sales by Application (2016-2021e) & (K Units)
Table 51. North America Malaria Vaccines Sales by Application (2021-2026) & (K Units)
Table 52. Europe Malaria Vaccines Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Malaria Vaccines Sales by Country (2021-2026) & (K Units)
Table 54. Europe Malaria Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Malaria Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Malaria Vaccines Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Malaria Vaccines Sales by Type (2021-2026) & (K Units)
Table 58. Europe Malaria Vaccines Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Malaria Vaccines Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Malaria Vaccines Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Malaria Vaccines Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Malaria Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Malaria Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Malaria Vaccines Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Malaria Vaccines Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Malaria Vaccines Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Malaria Vaccines Sales by Application (2021-2026) & (K Units)
Table 68. South America Malaria Vaccines Sales by Country (2016-2021e) & (K Units)
Table 69. South America Malaria Vaccines Sales by Country (2021-2026) & (K Units)
Table 70. South America Malaria Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Malaria Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Malaria Vaccines Sales by Type (2016-2021e) & (K Units)
Table 73. South America Malaria Vaccines Sales by Type (2021-2026) & (K Units)
Table 74. South America Malaria Vaccines Sales by Application (2016-2021e) & (K Units)
Table 75. South America Malaria Vaccines Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Malaria Vaccines Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Malaria Vaccines Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Malaria Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Malaria Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Malaria Vaccines Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Malaria Vaccines Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Malaria Vaccines Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Malaria Vaccines Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Malaria Vaccines Typical Distributors
Table 87. Malaria Vaccines Typical Customers
List of Figures
Figure 1. Malaria Vaccines Picture
Figure 2. Global Malaria Vaccines Sales Market Share by Type in 2020
Figure 3. Pre-Erythrocytic Vaccine
Figure 4. Erythrocytic Vaccine
Figure 5. Multi-antigen Vaccine
Figure 6. Global Malaria Vaccines Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Community Centers
Figure 10. Global Malaria Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Malaria Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Malaria Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Malaria Vaccines Sales (2016-2026) & (K Units)
Figure 32. Global Malaria Vaccines Production Capacity (2016-2026) & (K Units)
Figure 33. Global Malaria Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Malaria Vaccines Market Drivers
Figure 35. Malaria Vaccines Market Restraints
Figure 36. Malaria Vaccines Market Trends
Figure 37. Global Malaria Vaccines Sales Market Share by Manufacturer in 2020
Figure 38. Global Malaria Vaccines Revenue Market Share by Manufacturer in 2020
Figure 39. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Malaria Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Malaria Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Malaria Vaccines Sales Market Share by Region (2016-2026)
Figure 43. Global Malaria Vaccines Revenue Market Share by Region (2016-2026)
Figure 44. North America Malaria Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Europe Malaria Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Malaria Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. South America Malaria Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Malaria Vaccines Revenue (2016-2026) & (USD Million)
Figure 49. Global Malaria Vaccines Sales Market Share by Type (2016-2026)
Figure 50. Global Malaria Vaccines Revenue Market Share by Type (2016-2026)
Figure 51. Global Malaria Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Malaria Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Global Malaria Vaccines Revenue Market Share by Application (2016-2026)
Figure 54. Global Malaria Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Malaria Vaccines Sales Market Share by Country (2016-2026)
Figure 56. North America Malaria Vaccines Revenue Market Share by Country (2016-2026)
Figure 57. North America Malaria Vaccines Sales Market Share by Type (2016-2026)
Figure 58. North America Malaria Vaccines Sales Market Share by Application (2016-2026)
Figure 59. Europe Malaria Vaccines Sales Market Share by Country (2016-2026)
Figure 60. Europe Malaria Vaccines Revenue Market Share by Country (2016-2026)
Figure 61. Europe Malaria Vaccines Sales Market Share by Type (2016-2026)
Figure 62. Europe Malaria Vaccines Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Malaria Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Malaria Vaccines Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Malaria Vaccines Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Malaria Vaccines Sales Market Share by Application (2016-2026)
Figure 67. South America Malaria Vaccines Sales Market Share by Country (2016-2026)
Figure 68. South America Malaria Vaccines Revenue Market Share by Country (2016-2026)
Figure 69. South America Malaria Vaccines Sales Market Share by Type (2016-2026)
Figure 70. South America Malaria Vaccines Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Malaria Vaccines Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Malaria Vaccines Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Malaria Vaccines Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Malaria Vaccines Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のマラリア迅速診断検査（RDT）市場規模・現状・予測（2021年-2027年） Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services. Market Analysis …- 世界のマラリア迅速診断検査（RDT）市場規模・現状・予測（2021年-2027年） Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services. Market Analysis …
- 世界のマラリア診断市場規模・現状・予測（2021年-2027年） Malaria Diagnostics is the procedure to test if the patient have the Malaria . Market Analysis and Insights: Global Malaria Diagnostics Market The global Malaria Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With…
- 世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…
- 世界のマラリア迅速診断検査（RDT）市場 2021：企業別、地域別、種類・用途別 The Malaria rapid diagnostic tests (RDTs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…